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Non­Invasive Fully Quantitative Positron Emission Tomography 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Francesca Zanderigo, PhD    PROJECT ABSTRACT  Positron  emission  tomography  (PET),  a  nuclear  imaging  technology  for  in  vivo quantification of blood flow, metabolism, and protein distribution,  is an  invaluable tool  for developing novel personalized  therapies  for high morbidity  and mortality brain disorders (Benton et al., 2007; Depression Guideline Panel, 1999; Michalak et 
al., 2008; Trivedi, 2003; Vogt et al., 1994).  PET  gold‐standard  full  quantification  involves  determining  the  plasmatic concentration  of  the  injected  radioligand,  corrected  for  the  fraction  that  is metabolized in the body (metabolite‐corrected input function, cIF), a step essential for  all  the  radioligands  used  in  neuroreceptors  studies  other  than  [18F]FDG.  This invasive and costly procedure, that requires arterial catheter insertion and analysis of several blood samples, is difficult to apply in clinical practice, but it represents the only way to obtain in vivo the closest quantification to in vitro receptor density, the binding potential (BPF) (Innis et al., 2007).  Reference  region  approaches  (RRA)  (Cunningham  et  al.,  1991;  Ichise  et  al., 2003;  Lammertsma  et  al.,  1996;  Logan  et  al.,  1996)  avoid  arterial  sampling  by “considering as input” the radioligand activity in a reference region (RR) devoid of the receptors of interest. More precisely, they form an inferred relationship between regions based on the fact  that such regions share the cIF, and the assumption that the  non‐displaceable  volume  of  distribution  (VND)  of  the  radioligand,  ideally  the volume of distribution in a RR devoid of specific binding, is constant throughout the brain. However, RRA  (i) require the identification of a reliable RR (Oquendo et al., 2007; Parsey et 
al., 2005; Parsey et al., 2010); and  (ii)  only  estimate  the  non‐displaceable  binding  potential  BPND  (Innis  et  al., 2007; Slifstein et al., 2001), an outcome much less informative than BPF.  Thus,  measuring  cIF  is  key  for  many  radioligands  for  which  RR  is  not available  (Ginovart  et  al.,  2006;  Henriksen  et  al.,  2008),  and  for  correctly interpreting PET binding (Parsey et al., 2006; Parsey et al., 2010).  Tremendous progress has been achieved (Zanotti‐Fregonara et al., 2011a) in the  effort  to  reduce  or  eliminate  the  amount  of  arterial  blood  required,  while maintaining  quantification  accuracy  relative  to  the  cIF  analysis,  including  image‐derived input function approaches (IDIF) (Zanotti‐Fregonara et al., 2011a; Zanotti‐Fregonara  et  al.,  2011b).  However,  none  of  these  so‐called  non‐invasive methods has so  far  shown  the potential  to be  introduced  in  the  future  into clinical practice due to three major limitations (Zanotti‐Fregonara et al., 2011a; Zanotti‐Fregonara et 
al., 2011b).  (a) None works effectively for more than one radioligand.  (b) None per se accounts for metabolite correction.  
(c)  They  still  require  multiple  arterial  samples  for  correction/scaling purpose.  Simultaneous estimation (SIME) (Wong et al., 2002) of cIF and tissue kinetic constants has the potential to achieve a truly non‐invasive cIF estimation (Zanotti‐Fregonara  et  al.,  2011a),  given  that  it  (a)  is  promising  for  multiple  radioligands (Ogden et al., 2010; Zanotti‐Fregonara et al., 2011a), and (b) accounts for metabolite correction. Still, the need for one blood sample for scaling the cIF is a major barrier for its use in clinical practice.  We hypothesize  that we  can  predict  in  each  subject  the  scaling  needed  for SIME solely on the basis of non‐invasive biometric measurements (e.g. net injected dose  and mass,  body mass  index,  age),  thus  solving  one  of  the  biggest  challenges that hamper the routine use of PET in brain studies, the need for arterial blood. This will  be  tested  on  an  already  acquired  rich  PET  archive,  which  includes  arterial sampling  and  correlated  biometric  measurements  for  several  radioligands  and subjects. 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